Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Effect of interferon-β1α therapy on multiple sclerosis based on gadolinium-enhancing or active T2 magnetic resonance imaging outcomes: a meta-analysis.
Children with multiple sclerosis should not become therapeutic hostages.
Neurological Manifestations in Familial Mediterranean Fever: Results of 22 Children from a Reference Center in Kayseri, an Urban Area in Central Anatolia, Turkey.
Negative interaction between smoking and EBV in the risk of multiple sclerosis: The EnvIMS study.
The neuronal metabolite NAA regulates histone H3 methylation in oligodendrocytes and myelin lipid composition.
IL-12/IL-23p40 Is Highly Expressed in Secondary Lymphoid Organs and the CNS during All Stages of EAE, but Its Deletion Does Not Affect Disease Perpetuation.
WAIS-IV GAI and CPI discrepancies in multiple sclerosis and traumatic brain injury.
Real-World Outcomes in Fingolimod-Treated Patients with Multiple Sclerosis in the Czech Republic: Results from the 12-Month GOLEMS Study.
Is Time to Reach EDSS 6.0 Faster in Patients with Late-Onset versus Young-Onset Multiple Sclerosis?
A pilot study of changes in functional brain activity during a working memory task after mSMT treatment: The MEMREHAB trial.
Factitious Graves' disease due to biotin immunoassay interference - A case and review of the literature.
Myelin Sheath Injury in Kaolin-Induced Hydrocephalus: A Light and Electron Microscopy Study.
Germinoma Mimicking Tumefactive Demyelinating Disease in Pediatric Patients.
Novel Insights into Acid-Sensing Ion Channels: Implications for Degenerative Diseases.
Quality of life in relapsing-remitting multiple sclerosis patients receiving CinnoVex compared with Avonex.
Fatigue in Multiple Sclerosis: Misconceptions and Future Research Directions.
Tamoxifen accelerates the repair of demyelinated lesions in the central nervous system.
Multiple sclerosis: Successful trial of amiselimod for multiple sclerosis.
Multiple sclerosis: Biomarkers and genetic variants reflect disease course in multiple sclerosis.
Vertebral hemangiomas in the thoracic spine of multiple sclerosis patients are connected with fewer demyelinating lesions at the same level. Possible impact on pathophysiology and clinical course.
Tamoxifen: an FDA approved drug with neuroprotective effects for spinal cord injury recovery.
Linked Patient-Reported Outcomes Data From Patients With Multiple Sclerosis Recruited on an Open Internet Platform to Health Care Claims Databases Identifies a Representative Population for Real-Life Data Analysis in Multiple Sclerosis.
Inflammatory demyelinating neuropathy heralding accelerated Chediak-Higashi syndrome.
In vivo detection of connectivity between cortical and white matter lesions in early MS.
Voluntary Running Triggers VGF-Mediated Oligodendrogenesis to Prolong the Lifespan of Snf2h-Null Ataxic Mice.
Pages
« first
‹ previous
…
845
846
847
848
849
850
851
852
853
…
next ›
last »